Company / FCF Margin
Allogene Therapeutics, Inc. FCF Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-251841.0%
FY2024
5-year range
-251841.0% / -180.8%
FY2022-FY2024
Trend
-139200.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -139200% YoY in FY2024, a notable deviation from the 2-year average annual change of -69550%.
Based on SEC 10-K filings.
-251841.0% in FY2024.
Declined from -112581.5% to -251841.0% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin decreased 139200.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -251841.0% | -139200.3% |
| FY2023 | -180.8% | +99.8% |
| FY2022 | -112581.5% | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026